Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis

Neutrophil-like Cell-Membrane-Coated Nanozyme Therapy for Ischemic Brain Damage and Long-Term Neurological Functional Recovery

(2021) Lishuai Feng et al.   ACS Nano

Excavating bioactivities of nanozyme to remodel microenvironment for protecting chondrocytes and delaying osteoarthritis

(2021) Weiduo Hou et al.   Bioactive Materials

Tumor Metabolism‐Engineered Composite Nanoplatforms Potentiate Sonodynamic Therapy via Reshaping Tumor Microenvironment and Facilitating Electron–Hole Pairs’ Separation

(2020) Xin Guan et al.   ADVANCED FUNCTIONAL MATERIALS

Continuous inertial cavitation evokes massive ROS for reinforcing sonodynamic therapy and immunogenic cell death against breast carcinoma

(2020) Yifei Yin et al.   Nano Today

Hollow Prussian Blue Nanozymes Drive Neuroprotection against Ischemic Stroke via Attenuating Oxidative Stress, Counteracting Inflammation, and Suppressing Cell Apoptosis

(2019) Kai Zhang et al.   NANO LETTERS

Extravascular gelation shrinkage-derived internal stress enables tumor starvation therapy with suppressed metastasis and recurrence

(2019) Kun Zhang et al.   Nature Communications

Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline

(2019) Xiaojun Cai et al.   BIOMATERIALS

Prussian Blue Nanozyme with Multi-enzyme Activity Reduces Colitis in Mice

(2018) Jiulong Zhao et al.   ACS Applied Materials & Interfaces

Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis

(2018) Manse Kim et al.   JOURNAL OF CONTROLLED RELEASE

Coordination-Responsive Longitudinal Relaxation Tuning as a Versatile MRI Sensing Protocol for Malignancy Targets

(2018) Kun Zhang et al.   Advanced Science

Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity

(2018) Yuquan Wang et al.   ACS Nano

Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches

(2018) Julian Bejarano et al.   Theranostics

H2O2-responsive liposomal nanoprobe for photoacoustic inflammation imaging and tumor theranostics via in vivo chromogenic assay

(2017) Qian Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recent Advances in Managing Atherosclerosis via Nanomedicine

(2017) Cecilia Ka Wing Chan et al.   Small

Multimodality Imaging of Angiogenesis in a Rabbit Atherosclerotic Model by GEBP11 Peptide Targeted Nanoparticles

(2017) Tao Su et al.   Theranostics

Prussian Blue Nanoparticles as Multienzyme Mimetics and Reactive Oxygen Species Scavengers

(2016) Wei Zhang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy

(2016) Peng Mi et al.   Nature Nanotechnology

Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Disease

(2012) Kai Chen et al.   Current Atherosclerosis Reports

Macrophages in the Pathogenesis of Atherosclerosis

(2011) Kathryn J. Moore et al.   CELL

Progress and challenges in translating the biology of atherosclerosis

(2011) Peter Libby et al.   NATURE

The immune system in atherosclerosis

(2011) Göran K Hansson et al.   NATURE IMMUNOLOGY